1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY USED FOR THE STUDY 25
1.5 STAKEHOLDERS 25
1.6 SUMMARY OF CHANGES 25

2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 1 GLOBAL BREAST BIOPSY MARKET: RESEARCH METHODOLOGY STEPS 28
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
2.1.2.1 Breakdown of primaries 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31
2.1.2.2 Key data from primary sources 32
2.2 MARKET SIZE ESTIMATION 33
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 33
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION 33
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 34
2.2.2 END USER-BASED MARKET SIZE ESTIMATION 34
FIGURE 6 BREAST BIOPSY MARKET: END USER BASED ESTIMATION 35
2.2.3 PRIMARY RESEARCH VALIDATION 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 36
FIGURE 7 DATA TRIANGULATION METHODOLOGY 36
2.4 RESEARCH LIMITATIONS 37

3 EXECUTIVE SUMMARY 38
FIGURE 8 BREAST BIOPSY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 38
FIGURE 9 BREAST BIOPSY MARKET SHARE, BY TYPE, 2020 VS. 2025 39
FIGURE 10 BREAST BIOPSY MARKET, BY GUIDANCE, 2020 VS. 2025 (USD MILLION) 39
FIGURE 11 BREAST BIOPSY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 40
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF BREAST BIOPSY MARKET 41

4 PREMIUM INSIGHTS 42
4.1 BREAST BIOPSY: MARKET OVERVIEW 42
FIGURE 13 INCREASING PREVALENCE OF BREAST CANCER DRIVING GROWTH OF BREAST BIOPSY MARKET ACROSS THE GLOBE 42
4.2 GEOGRAPHIC ANALYSIS: BREAST BIOPSY MARKET, BY PRODUCT AND REGION 43
FIGURE 14 ASSAY KITS SEGMENT WILL WITNESS HIGH GROWTH IN THE NORTH AMERICA MARKET IN 2025 43
4.3 GEOGRAPHIC ANALYSIS: NEEDLE BREAST BIOPSY MARKET, BY TYPE AND REGION 44
FIGURE 15 CORE NEEDLE BIOPSY SEGMENT DOMINATED THE ASIA PACIFIC NEEDLE BREAST BIOPSY MARKET IN 2020 44
4.4 LIQUID BREAST BIOPSY MARKET, BY GUIDANCE 44
FIGURE 16 NGS-BASED BIOPSY TO REGISTER SIGNIFICANT GROWTH IN THE GLOBAL LIQUID BIOPSY MARKET, BY GUIDANCE 44
4.5 GEOGRAPHIC ANALYSIS: BREAST BIOPSY MARKET, BY APPLICATION AND REGION 45
FIGURE 17 EARLY CANCER SCREENING IS KEY APPLICATION IN EUROPEAN BREAST BIOPSY MARKET; THERAPY SELECTION TO REGISTER SUBSTANTIAL GROWTH 45
4.6 GEOGRAPHIC SNAPSHOT OF THE BREAST BIOPSY MARKET 46
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 46

5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 19 BREAST BIOPSY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Growing incidence of breast cancer 48
FIGURE 20 NUMBER OF BREAST CANCER CASES IN 2018, BY KEY COUNTRIES 48
5.2.1.2 Increasing number of breast cancer screening programs 49
5.2.1.3 Increasing demand for minimally invasive and non-invasive procedures 49
5.2.1.4 Growing awareness regarding early detection of breast cancer 50
5.2.1.5 Improved reimbursement scenario 50
TABLE 1 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY 51
5.2.2 RESTRAINTS 52
5.2.2.1 Risk of infections associated with the use of biopsy needles 52
5.2.2.2 Stringent regulatory approval procedures 52
5.2.2.3 Product recalls 53
TABLE 2 FDA INITIATED PRODUCT RECALLS 53
5.2.3 OPPORTUNITIES 53
5.2.3.1 Emerging economies offer high growth potential 53
5.2.3.2 Emergence of liquid biopsy and promising clinical trials 54
TABLE 3 LIQUID BIOPSY CLINICL TRIALS 54
5.2.3.3 Increasing public–private investments and funding 55
5.2.4 CHALLENGES 55
5.2.4.1 Underdeveloped healthcare infrastructure and dearth of resources in developing countries 55
5.3 VALUE CHAIN ANALYSIS 56
5.4 ECOSYSTEM: BREAST BIOPSY MARKET 57
5.5 TECHNOLOGY ANALYSIS 57
5.6 IMPACT OF COVID-19 ON BREAST BIOPSY MARKET 57

6 BREAST BIOPSY MARKET, BY PRODUCT 59
6.1 INTRODUCTION 60
TABLE 4 BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 60
TABLE 5 BREAST BIOPSY MARKET, BY REGION, 2018–2025 (USD MILLION) 60
6.2 BIOPSY NEEDLES 61
6.2.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE REVENUE GROWTH 61
TABLE 6 BIOPSY NEEDLES MARKET, BY REGION, 2018–2025 (USD MILLION) 61
6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 62
TABLE 7 BIOPSY NEEDLES MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 62
6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY GUIDANCE, 2018–2025 (USD MILLION) 62
TABLE 8 BIOPSY NEEDLES MARKET SPLIT, BY GUIDANCE, 2018–2025 (USD MILLION) 62
6.2.4 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 63
TABLE 9 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 63
6.3 GUIDANCE SYSTEMS 63
6.3.1 PROCEDURAL ADVANTAGES OF GUIDED BIOPSIES TO FUEL RAPID MARKET EXPANSION 63
TABLE 10 GUIDANCE SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 64
6.3.2 GUIDANCE SYSTEMS MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 64
TABLE 11 GUIDANCE SYSTEMS MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 64
6.3.3 GUIDANCE SYSTEMS MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 65
TABLE 12 GUIDANCE SYSTEMS MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 65
6.3.4 GUIDANCE SYSTEMS MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 65
TABLE 13 GUIDANCE SYSTEMS MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 65
6.4 BIOPSY TABLES 66
6.4.1 INCREASINGLY USED TO PERFORM STEREOTACTIC BIOPSY PROCEDURES 66
TABLE 14 BIOPSY TABLES MARKET, BY REGION, 2018–2025 (USD MILLION) 66
6.4.2 BIOPSY TABLES MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 66
TABLE 15 BIOPSY TABLES MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 66
6.4.3 BIOPSY TABLES MARKET SPLIT, BY GUIDANCE, 2018–2025 (USD MILLION) 67
TABLE 16 BIOPSY TABLES MARKET SPLIT, BY GUIDANCE, 2018–2025 (USD MILLION) 67
6.4.4 BIOPSY TABLES MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 67
TABLE 17 BIOPSY TABLES MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 67
6.5 ASSAY KITS 68
6.5.1 PRODUCT APPROVAL AND LAUNCHES DRIVING SEGMENT GROWTH 68
TABLE 18 ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 68
6.5.2 ASSAY KITS MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 68
TABLE 19 ASSAY KITS MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 68
6.5.3 ASSAY KITS MARKET SPLIT, BY GUIDANCE, 2018–2025 (USD MILLION) 69
TABLE 20 ASSAY KITS MARKET SPLIT, BY GUIDANCE, 2018–2025 (USD MILLION) 69
6.5.4 ASSAY KITS MARKET SPLIT, BY APPLICATION, 2018–2025 (USD MILLION) 69
TABLE 21 ASSAY KITS MARKET SPLIT, BY APPLICATION, 2018–2025 (USD MILLION) 69
6.6 LIQUID BIOPSY INSTRUMENTS 69
6.6.1 ONGOING RESEARCH AND CLINICAL TRIALS EXPECTED TO DELIVER NOVEL SOLUTIONS IN THE MARKET 69
TABLE 22 LIQUID BIOPSY INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 70
6.6.2 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY TYPE,
2018–2025 (USD MILLION) 70
TABLE 23 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY TYPE,
2018–2025 (USD MILLION) 70
6.6.3 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 71
TABLE 24 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 71
6.6.4 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 71
TABLE 25 LIQUID BIOPSY INSTRUMENTS MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 71
6.7 LOCALIZATION WIRES 72
6.7.1 MOST COMMONLY USED TO LOCATE BREAST ABNORMALITIES AND LUMPS 72
TABLE 26 LOCALIZATION WIRES MARKET, BY REGION, 2018–2025 (USD MILLION) 72
6.7.2 LOCALIZATION WIRES MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 72
TABLE 27 LOCALIZATION WIRES MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 72
6.7.3 LOCALIZATION WIRES MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 73
TABLE 28 LOCALIZATION WIRES MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 73
6.7.4 LOCALIZATION WIRES MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 73
TABLE 29 LOCALIZATION WIRES MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 73
6.8 OTHER PRODUCTS 73
6.8.1 RISING PATIENT POPULATION AND INCREASING ADOPTION OF BIOPSY PROCEDURES TO SUPPORT SEGMENT GROWTH 73
TABLE 30 OTHER PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION) 74
6.8.2 OTHER PRODUCTS MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 74
TABLE 31 OTHER PRODUCTS MARKET SPLIT, BY TYPE, 2018–2025 (USD MILLION) 74
6.8.3 OTHER PRODUCTS MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 75
TABLE 32 OTHER PRODUCTS MARKET SPLIT, BY GUIDANCE,
2018–2025 (USD MILLION) 75
6.8.4 OTHER PRODUCTS MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 75
TABLE 33 OTHER PRODUCTS MARKET SPLIT, BY APPLICATION,
2018–2025 (USD MILLION) 75

7 BREAST BIOPSY MARKET, BY TYPE 76
7.1 INTRODUCTION 77
TABLE 34 BREAST BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 77
7.2 NEEDLE BREAST BIOPSY 77
TABLE 35 BREAST BIOPSY MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE,
2018–2025 (USD MILLION) 77
7.2.1 CORE NEEDLE BIOPSY 78
7.2.1.1 Procedural advantages of guidance system-based biopsy to drive revenue growth 78
TABLE 36 BREAST BIOPSY MARKET FOR CORE NEEDLE BIOPSY, BY REGION,
2018–2025 (USD MILLION) 78
7.2.2 VACUUM-ASSISTED BIOPSY (VAB) 78
7.2.2.1 Technological advantages supporting growth of segment 78
TABLE 37 BREAST BIOPSY MARKET FOR VACUUM-ASSISTED BIOPSY,
BY REGION, 2018–2025 (USD MILLION) 79
7.2.3 FINE NEEDLE ASPIRATION BIOPSY (FNAB) 79
7.2.3.1 Increasingly being replaced by core needle biopsy procedures 79
TABLE 38 BREAST BIOPSY MARKET FOR FINE NEEDLE ASPIRATION BIOPSY,
BY REGION, 2018–2025 (USD MILLION) 80
7.3 OPEN SURGICAL BREAST BIOPSY 80
TABLE 39 BREAST BIOPSY MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2018–2025 (USD MILLION) 80
7.3.1 EXCISIONAL 81
7.3.1.1 Risk of post-operative complications hindering growth of segment 81
TABLE 40 BREAST BIOPSY MARKET FOR EXCISIONAL, BY REGION,
2018–2025 (USD MILLION) 81
7.3.2 INCISIONAL 81
7.3.2.1 Performed when size of tumor is quite large 81
TABLE 41 BREAST BIOPSY MARKET FOR INCISIONAL, BY REGION,
2018–2025 (USD MILLION) 82
7.4 LIQUID BREAST BIOPSY 82
TABLE 42 BREAST BIOPSY MARKET FOR LIQUID BREAST BIOPSY, BY TYPE,
2018–2025 (USD MILLION) 82
7.4.1 CIRCULATING TUMOR CELLS 83
7.4.1.1 Difficult to identify limited presence in blood sample 83
TABLE 43 BREAST BIOPSY MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2018–2025 (USD MILLION) 83
7.4.2 CIRCULATING TUMOR DNA (CTDNA) 84
7.4.2.1 Promising blood-based biomarker to monitor disease status 84
TABLE 44 BREAST BIOPSY MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2018–2025 (USD MILLION) 84
7.4.3 OTHER BIOMARKERS 85
7.4.3.1 Cell-free mRNA, miRNA, and tumor-educated platelets (TEP) used for early detection 85
TABLE 45 BREAST BIOPSY MARKET FOR OTHER BIOMARKERS, BY REGION,
2018–2025 (USD MILLION) 85

8 BREAST BIOPSY MARKET, BY GUIDANCE 86
8.1 INTRODUCTION 87
TABLE 46 BREAST BIOPSY MARKET, BY GUIDANCE, 2018–2025 (USD MILLION) 87
8.2 IMAGE GUIDED BIOPSY 87
TABLE 47 BREAST BIOPSY MARKET FOR IMAGE GUIDED BIOPSY, BY TYPE,
2018–2025 (USD MILLION) 87
8.2.1 MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY 88
8.2.1.1 Increasing government-initiated breast screening programs to drive segment growth 88
TABLE 48 BREAST BIOPSY MARKET FOR MAMMOGRPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2018–2025 (USD MILLION) 88
8.2.2 ULTRASOUND-GUIDED BIOPSY 88
8.2.2.1 Advantages of technique resulting in rising adoption 88
TABLE 49 BREAST BIOPSY MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018–2025 (USD MILLION) 89
8.2.3 MRI GUIDED BIOPSY 89
8.2.3.1 High cost and low specificity affecting segment growth 89
TABLE 50 BREAST BIOPSY MARKET FOR MRI GUIDED BIOPSY, BY REGION,
2018–2025 (USD MILLION) 90
8.2.4 OTHER GUIDANCE TECHNIQUES 90
8.2.4.1 Ongoing research and clinical trials creating more opportunities in the market 90
TABLE 51 BREAST BIOPSY MARKET FOR OTHER GUIDANCE TECHNIQUES,
BY REGION, 2018–2025 (USD MILLION) 91
8.3 LIQUID BIOPSY 91
TABLE 52 BREAST BIOPSY MARKET FOR LIQUID BIOPSY, BY TYPE,
2018–2025 (USD MILLION) 91
8.3.1 PCR-BASED BIOPSY 92
8.3.1.1 Expected to hold major share of market over forecast period 92
TABLE 53 BREAST BIOPSY MARKET FOR PCR-BASED BIOPSY, BY REGION,
2018–2025 (USD MILLION) 92
8.3.2 NGS-BASED BIOPSY 92
8.3.2.1 Technological advancements and advantages expected to
drive growth 92
TABLE 54 NGS-BASED TECHNOLOGIES FOR ONCOLOGY APPLICATIONS 93
TABLE 55 BREAST BIOPSY MARKET FOR NGS-BASED BIOPSY, BY REGION,
2018–2025 (USD MILLION) 94
8.3.3 MICROARRAY-BASED BIOPSY 94
8.3.3.1 Ongoing research and promising results expected to drive
segment growth 94
TABLE 56 BREAST BIOPSY MARKET FOR MICROARRAY-BASED BIOPSY, BY REGION, 2018–2025 (USD MILLION) 95

9 BREAST BIOPSY MARKET, BY APPLICATION 96
9.1 INTRODUCTION 97
TABLE 57 BREAST BIOPSY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 97
9.2 EARLY CANCER SCREENING 97
9.2.1 GROWING AWARENESS ABOUT EARLY CANCER DETECTION DRIVING SEGMENT GROWTH 97
TABLE 58 BREAST BIOPSY MARKET FOR EARLY CANCER SCREENING, BY REGION, 2018–2025 (USD MILLION) 98
9.3 THERAPY SELECTION 98
9.3.1 EMERGENCE OF PLASMA-BASED GENOTYPING EXPECTED TO DRIVE GROWTH IN DEVELOPED COUNTRIES 98
TABLE 59 BREAST BIOPSY MARKET FOR THERAPY SELECTION, BY REGION,
2018–2025 (USD MILLION) 99
9.4 TREATMENT MONITORING 99
9.4.1 LIQUID BIOPSY GAINING ATTENTION FOR REAL TIME TREATMENT MONITORING 99
TABLE 60 BREAST BIOPSY MARKET FOR TREATMENT MONITORING, BY REGION,
2018–2025 (USD MILLION) 100
9.5 RECURRENCE MONITORING 100
9.5.1 UNMET CLINICAL NEEDS CREATING OPPORTUNITIES FOR PLAYERS IN THE MARKET 100
TABLE 61 BREAST BIOPSY MARKET FOR RECURRENCE MONITORING, BY REGION, 2018–2025 (USD MILLION) 101

10 BREAST BIOPSY MARKET, BY REGION 102
10.1 INTRODUCTION 103
TABLE 62 BREAST BIOPSY MARKET, BY REGION, 2018–2025 (USD MILLION) 103
10.2 NORTH AMERICA 103
FIGURE 21 NORTH AMERICA: BREAST BIOPSY MARKET SNAPSHOT 104
TABLE 63 NORTH AMERICA: BREAST BIOPSY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 104
TABLE 64 NORTH AMERICA: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 105
TABLE 65 NORTH AMERICA: BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 105
TABLE 66 NORTH AMERICA: NEEDLE BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 105
TABLE 67 NORTH AMERICA: OPEN SURGICAL BREAST BIOPSY MARKET,
BY TYPE, 2018–2025 (USD MILLION) 106
TABLE 68 NORTH AMERICA: LIQUID BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 106
TABLE 69 NORTH AMERICA: BREAST BIOPSY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 106
TABLE 70 NORTH AMERICA: BREAST BIOPSY MARKET, BY GUIDANCE,
2018–2025 (USD MILLION) 107
TABLE 71 NORTH AMERICA: IMAGE GUIDED BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
TABLE 72 NORTH AMERICA: LIQUID BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
10.2.1 US 108
10.2.1.1 Dominates the North American breast biopsy market 108
TABLE 73 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY PROCEDURES (2020) 108
TABLE 74 US: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 109
10.2.2 CANADA 110
10.2.2.1 Surge in breast cancer incidence and favorable government guidelines to support market growth 110
TABLE 75 CANADA: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 110
10.3 EUROPE 111
TABLE 76 EUROPE: BREAST BIOPSY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 111
TABLE 77 EUROPE: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 111
TABLE 78 EUROPE: BREAST BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 79 EUROPE: NEEDLE BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 80 EUROPE: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 81 EUROPE: LIQUID BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
TABLE 82 EUROPE: BREAST BIOPSY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 113
TABLE 83 EUROPE: BREAST BIOPSY MARKET, BY GUIDANCE,
2018–2025 (USD MILLION) 113
TABLE 84 EUROPE: IMAGE GUIDED BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 114
TABLE 85 EUROPE: LIQUID BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 114
10.3.1 GERMANY 114
10.3.1.1 Favorable reimbursement scenario to fuel adoption of biopsy tests 114
TABLE 86 GERMANY: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 115
10.3.2 UK 115
10.3.2.1 Public and private initiatives to increase awareness about breast cancer 115
TABLE 87 UK: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 116
10.3.3 FRANCE 116
10.3.3.1 Growing geriatric population and rising awareness to support market growth 116
TABLE 88 FRANCE: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 117
10.3.4 ITALY 117
10.3.4.1 Evolving regulatory scenario for breast biopsy and rising incidence of cancer driving market 117
TABLE 89 ITALY: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 118
10.3.5 SPAIN 118
10.3.5.1 Growing geriatric population major reason for market growth 118
TABLE 90 SPAIN: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 119
10.3.6 REST OF EUROPE 119
TABLE 91 ROE: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 120
10.4 ASIA PACIFIC 120
FIGURE 22 ASIA PACIFIC: BREAST BIOPSY MARKET SNAPSHOT 121
TABLE 92 ASIA PACIFIC: BREAST BIOPSY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 122
TABLE 93 ASIA PACIFIC: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 122
TABLE 94 ASIA PACIFIC: BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 95 ASIA PACIFIC: NEEDLE BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 96 ASIA PACIFIC: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 97 ASIA PACIFIC: LIQUID BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 98 ASIA PACIFIC: BREAST BIOPSY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 124
TABLE 99 ASIA PACIFIC: BREAST BIOPSY MARKET, BY GUIDANCE,
2018–2025 (USD MILLION) 124
TABLE 100 ASIA PACIFIC: IMAGE GUIDED BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 101 ASIA PACIFIC: LIQUID BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 125
10.4.1 CHINA 125
10.4.1.1 Increasing patient pool and government healthcare initiatives fueling market growth 125
TABLE 102 CHINA: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 126
10.4.2 JAPAN 126
10.4.2.1 Universal healthcare reimbursement scenario and rising breast cancer cases 126
TABLE 103 JAPAN: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 127
10.4.3 INDIA 127
10.4.3.1 Government initiatives to improve female health to drive market growth 127
TABLE 104 INDIA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 128
10.4.4 AUSTRALIA 128
10.4.4.1 Rising research investments and awareness campaigns supporting market growth 128
TABLE 105 AUSTRALIA: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 129
10.4.5 SOUTH KOREA 129
10.4.5.1 Rising R&D and promising clinical trials expected to positively impact market growth 129
TABLE 106 SOUTH KOREA: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 130
10.4.6 REST OF APAC 130
TABLE 107 ROAPAC: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 130
10.5 LATIN AMERICA 131
TABLE 108 LATIN AMERICA: BREAST BIOPSY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 131
TABLE 109 LATIN AMERICA: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 132
TABLE 110 LATIN AMERICA: BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 111 LATIN AMERICA: NEEDLE BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 112 LATIN AMERICA: OPEN SURGICAL BREAST BIOPSY MARKET,
BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 113 LATIN AMERICA: LIQUID BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 114 LATIN AMERICA: BREAST BIOPSY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 133
TABLE 115 LATIN AMERICA: BREAST BIOPSY MARKET, BY GUIDANCE,
2018–2025 (USD MILLION) 134
TABLE 116 LATIN AMERICA: IMAGE GUIDED BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 117 LATIN AMERICA: LIQUID BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
10.5.1 BRAZIL 135
10.5.1.1 Key market due to increased screening programs 135
TABLE 118 BRAZIL: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 135
10.5.2 MEXICO 136
10.5.2.1 Increasing awareness programs fueling market growth 136
TABLE 119 MEXICO: BREAST BIOPSY MARKET, BY PRODUCTS,
2018–2025 (USD MILLION) 136
10.5.3 REST OF LA 137
TABLE 120 ROLA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 137
10.5.4 MIDDLE EAST & AFRICA 138
10.5.4.1 Improving healthcare infrastructure and increasing public–private investments to drive market growth 138
TABLE 121 MEA: BREAST BIOPSY MARKET, BY PRODUCTS, 2018–2025 (USD MILLION) 138
TABLE 122 MEA: BREAST BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 123 MEA: NEEDLE BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 124 MEA: OPEN SURGICAL BREAST BIOPSY MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 125 MEA: LIQUID BREAST BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 126 MEA: BREAST BIOPSY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 140
TABLE 127 MEA: BREAST BIOPSY MARKET, BY GUIDANCE, 2018–2025 (USD MILLION) 140
TABLE 128 MEA: IMAGE GUIDED BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 141
TABLE 129 MEA: LIQUID BIOPSY MARKET, BY TYPE, 2018–2025 (USD MILLION) 141

11 COMPETITIVE LANDSCAPE 142
11.1 OVERVIEW 142
FIGURE 23 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM

2017 TO 2020 142
11.2 MARKET SHARE ANALYSIS 143
FIGURE 24 GLOBAL NEEDLE BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2019 143
FIGURE 25 GLOBAL LIQUID BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2019 143
11.3 KEY MARKET DEVELOPMENTS 144
11.3.1 PRODUCT LAUNCHES AND APPROVALS 144
11.3.2 ACQUISITIONS 145
11.3.3 PARTNERSHIPS AND AGREEMENTS 146

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 147
(Business Overview, Products Offered, Recent Developments, MNM view)*
12.1 COMPANY EVALUATION MATRIX AND METHODOLOGY 147
12.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019) 147
12.1.2 VISIONARY LEADERS 147
12.1.3 INNOVATORS 147
12.1.4 DYNAMIC DIFFERENTIATORS 148
12.1.5 EMERGING COMPANIES 148
12.2 COMPANY EVALUATION MATRIX, 2019 148
FIGURE 26 BREAST BIOPSY MARKET (GLOBAL) COMEPITIVE LEADERSHIP
MAPPING, 2019 148
12.3 COMPANY PROFILES 149
12.3.1 HOLOGIC, INC. 149
FIGURE 27 HOLOGIC, INC.: COMPANY SNAPSHOT 149
12.3.2 DANAHER CORPORATION 151
FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT 151
12.3.3 BECTON, DICKINSON AND COMPANY 153
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 153
12.3.4 ARGON MEDICAL 155
12.3.5 IZI MEDICAL PRODUCTS 156
12.3.6 MERIT MEDICAL SYSTEMS 157
FIGURE 30 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 157
12.3.7 MENARINI SILICON BIOSYSTEMS SPA 159
12.3.8 SCION MEDICAL TECHNOLOGIES, LLC 160
FIGURE 31 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 160
12.3.9 MEDTRONIC 162
FIGURE 32 MEDTRONIC: COMPANY SNAPSHOT 162
12.3.10 STERYLAB S.R.L. 164
12.3.11 BIOCEPT, INC 165
FIGURE 33 BIOCEPT INC.: COMPANY SNAPSHOT 165
12.3.12 BIO-RAD LABORATORIES, INC. 167
FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 167
12.3.13 F. HOFFMANN-LA ROCHE LTD 169
FIGURE 35 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT 169
12.3.14 QIAGEN 171
FIGURE 36 QIAGEN: COMPANY SNAPSHOT 171
12.3.15 EXACT SCIENCES CORPORATION 173
FIGURE 37 EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT 173
12.3.16 OTHER COMPANIES 174
12.3.16.1 Thermo Fisher Scientific 174
12.3.16.2 Cardiff Oncology, Inc. 174
12.3.16.3 Myriad Genetics, Inc. 175
12.3.16.4 Illumina, INC 175
12.3.16.5 Fluxion Biosciences, Inc. 176
*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.

13 APPENDIX 177
13.1 DISCUSSION GUIDE 177
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 184
13.3 AVAILABLE CUSTOMIZATIONS 186
13.4 RELATED REPORTS 186
13.5 AUTHOR DETAILS 187